228818
Diethyl propylmalonate
99%
Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
About This Item
Fórmula lineal:
CH3CH2CH2CH(COOC2H5)2
Número de CAS:
Peso molecular:
202.25
Beilstein/REAXYS Number:
510157
EC Number:
MDL number:
UNSPSC Code:
12352100
PubChem Substance ID:
NACRES:
NA.22
Productos recomendados
Quality Level
assay
99%
form
liquid
refractive index
n20/D 1.418 (lit.)
bp
221-222 °C (lit.)
density
0.987 g/mL at 25 °C (lit.)
SMILES string
CCCC(C(=O)OCC)C(=O)OCC
InChI
1S/C10H18O4/c1-4-7-8(9(11)13-5-2)10(12)14-6-3/h8H,4-7H2,1-3H3
InChI key
GRRSDGHTSMJICM-UHFFFAOYSA-N
¿Está buscando productos similares? Visita Guía de comparación de productos
Application
Diethyl propylmalonate was used in the synthesis of propylacrylic acid (PAA).
Storage Class
10 - Combustible liquids
wgk_germany
WGK 3
flash_point_f
197.6 °F - closed cup
flash_point_c
92 °C - closed cup
ppe
Eyeshields, Gloves, multi-purpose combination respirator cartridge (US)
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Mohamed E H El-Sayed et al.
Journal of controlled release : official journal of the Controlled Release Society, 104(2), 417-427 (2005-06-29)
Limited cytoplasmic delivery of enzyme-susceptible drugs remains a significant challenge facing the development of protein and nucleic acid therapies that act in intracellular compartments. "Smart" pH-responsive, membrane-destabilizing polymers present a new approach to shuttling therapeutic molecules past the endosomal membrane
Kyle M Hocking et al.
Tissue engineering. Part A, 25(5-6), 416-426 (2018-08-23)
Subarachnoid hemorrhage (SAH) is associated with vasospasm that is refractory to traditional vasodilators, and inhibition of vasospasm after SAH remains a large unmet clinical need. SAH causes changes in the phosphorylation state of the small heat shock proteins (HSPs), HSP20
Feng Qiu et al.
Biomaterials, 182, 82-91 (2018-08-15)
Cancer vaccines targeting patient-specific tumor neoantigens have recently emerged as a promising component of the rapidly expanding immunotherapeutic armamentarium. However, neoantigenic peptides typically elicit weak CD8+ T cell responses, and so there is a need for universally applicable vaccine delivery
Brian C Evans et al.
ACS nano, 9(6), 5893-5907 (2015-05-26)
A platform technology has been developed and tested for delivery of intracellular-acting peptides through electrostatically complexed nanoparticles, or nano-polyplexes, formulated from an anionic endosomolytic polymer and cationic therapeutic peptides. This delivery platform has been initially tested and optimized for delivery
Xi Zhan et al.
Pharmaceutical research, 32(7), 2280-2291 (2015-01-17)
A key step of delivering extracellular agents to its intracellular target is to escape from endosomal/lysosomal compartments, while minimizing the release of digestive enzymes that may compromise cellular functions. In this study, we examined the intracellular distribution of both fluorecent
Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.
Póngase en contacto con el Servicio técnico